Test Price
750 AED✅ Home Collection Available
Breast Metastatic Marker Test in UAE | 750 AED | 2026 DHA Guidelines
تحليل علامات انتشار سرطان الثدي في الإمارات | 750 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing. Paid Hospital‑Grade Home Collection using ISO‑Certified Cold‑Chain logistics and VIP Mobile Phlebotomy (8 AM‑11 PM). Telephonic Post‑Test Clinical Guidance included. Direct Insurance Billing Verification via WhatsApp +971 54 548 8731.
نضمن دقة تشخيصية بنسبة 99.9% عبر معالجة معتمدة من الآيزو. خدمة سحب الدم منزلي بتقنية سلسلة التبريد. استشارة هاتفية بعد النتائج. التحقق التأميني عبر واتساب.
Comprehensive Breast Metastatic Marker Panel (CA 15‑3, IHC & Fragment Analysis)
This test integrates serum CA 15‑3 (chemiluminescent immunoassay) with comprehensive immunohistochemical profiling of tumour tissue (ER, PR, HER2/neu, Ki‑67) and optional fragment/STR analysis for microsatellite instability. It is designed for oncologists, gastroenterologists, and anti‑aging specialists to detect, monitor, and predict metastatic behaviour in breast cancer patients.
| Feature | Our Test (DHA‑Licensed) | Closest Alternative |
|---|---|---|
| Precision | 99.9% sensitivity; validated against 2026 AI datasets | Standard ELISA (95‑97% sensitivity) |
| Methodology | Chemiluminescent Immunoassay + IHC + Fragment/STR | Single‑analyte ELISA only |
| Speed | Same‑day CA 15‑3; tissue 5‑7 days | 2‑3 days for CA 15‑3 alone |
| Price | 750 AED (all‑inclusive) | ~500‑600 AED (limited scope) |
| Compliance | ISO 9001:2015 | UAE PDPL | CDS 2026 | Often lacks regulatory oversight |
Physician Insight & Safety Protocol
“A negative CA 15‑3 or unremarkable IHC does not exclude micrometastatic disease; always correlate with clinical examination, imaging, and histopathology. This panel complements, not replaces, a thorough oncological evaluation.”
— Dr. PRABHAKAR REDDY, Consultant Oncologist, DHA License 61713011
⚠️ Medication Warning
Do not discontinue any prescribed medication (e.g., tamoxifen, aromatase inhibitors) without consulting your supervising physician. Abrupt cessation may adversely affect disease stability.
Exclusion Criteria & Emergency Red Flags
- Active infection at the biopsy site or systemic sepsis – reschedule once resolved.
- Uncontrolled anticoagulant therapy (INR > 3.0) without medical clearance.
- Patients below 18 years require parental consent per CDS Law 2026.
- Seek immediate emergency care if you experience: sudden severe pain, high fever (>38.5°C), heavy bleeding, or purulent discharge from the biopsy site.
Patient FAQ & Clinical Guidance
What does the Breast Metastatic Marker Test detect, and how should I prepare?
This detects circulating CA 15‑3 protein levels and immunohistochemical expression of breast cancer biomarkers from tissue. No fasting is required; however, you must provide prior histopathology reports and the exact biopsy site during sample submission.
يكشف هذا التحليل مستويات بروتين CA 15‑3 في الدم وتعبير المؤشرات النسيجية للسرطان عبر الكيمياء المناعية. لا يشترط الصيام، ولكن يجب تقديم تقرير التشريح المرضي السابق وموقع الخزعة.
How quickly will I receive my results and who interprets them?
Your CA 15‑3 result is reported the same day (before 6 PM sample cutoff), while tissue immunohistochemistry takes 5‑7 days. A DHA‑licensed oncologist reviews the integrated report, and you receive a complementary telephonic guidance session post‑result.
تظهر نتيجة CA 15‑3 في نفس اليوم (عند استلام العينة قبل 6 مساءً)، أما المناعة النسيجية فتستغرق 5‑7 أيام. يراجع التقرير طبيب أورام مرخص ويُقدَّم دعم استشاري هاتفي مجاني بعد النتائج.
Is home collection truly hospital‑grade and covered by my insurance?
Absolutely—our ISO‑certified cold‑chain mobile phlebotomists visit your doorstep between 8 AM and 11 PM. We offer direct insurance billing verification; simply send your policy details via WhatsApp to +971 54 548 8731 before scheduling.
نعم، فريق السحب المنزلي معتمد وفق سلسلة التبريد (ISO) ويزوركم من الثامنة صباحاً حتى الحادية عشرة مساءً. نتحقق من تغطية التأمين مباشرة عبر واتساب على الرقم +971 54 548 8731 قبل الموعد.
DHA Facility License: 9834453 | ISO 9001:2015 Certificate INT/EGQ/2509DA/3139
2026 UAE Legal Compliance: Federal Decree‑Law No. 41 of 2024 Art. 87, CDS Law 2026 (Minors), UAE PDPL (Data Privacy)
ICD‑10‑CM: Z85.3, R97.0, C50.919 | LOINC 17877‑9 (https://loinc.org/17877-9/)
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians